CC BY 4.0 · Surg J (N Y) 2019; 05(03): e65-e68
DOI: 10.1055/s-0039-1693040
Case Report
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Malignant Extra-Gastrointestinal Stromal Tumor of the Mesentery

Prakash K. Sasmal
1   Department of General Surgery, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
,
Rakesh Sharma
1   Department of General Surgery, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
,
Susama Patra
2   Department of Pathology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
,
Tushar S. Mishra
1   Department of General Surgery, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
,
Pritinanda Mishra
2   Department of Pathology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
,
Bikram Rout
1   Department of General Surgery, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
› Author Affiliations
Further Information

Publication History

18 February 2019

31 May 2019

Publication Date:
01 August 2019 (online)

Abstract

Gastrointestinal stromal tumors (GISTs), the commonest mesenchymal tumors of gastrointestinal tract are often described to take origin from the interstitial cells of Cajal (ICC) or its precursor cells. Rarely these tumors do arise in structures other than the alimentary tract like omentum, mesentery, retroperitoneum, etc., of varying malignant potential and are known as extra-gastrointestinal stromal tumors (eGISTs).

This is a case report of a 70-year-old female with multicentric malignant eGISTs arising in the mesentery of ileum. On laparotomy, a large mass of 20 × 15 cm was found in the small bowel mesentery without involvement of the adjacent ileum, with multiple other small nodules resembling lymph nodes, present adjacent to it. Histopathological study of the excised lump, confirmed the mass to be malignant eGIST without involvement of the adjacent ileum, with cluster differentiation (CD)117 positive and of high-risk stratification. The mesenteric nodule was confirmed on histopathology to be malignant eGIST, similar to that of that of the primary, without any lymphoid tissue. Adjuvant imatinib mesylate treatment was started immediately postoperation with the patient doing well at 1 year of follow-up. We report this case, due to the rare occurrence of multifocal malignant eGISTS of small bowel mesentery, which is yet to be reported. The existing literature is unclear regarding the clinicopathology and management of multifocal malignant stromal tumors of the mesentery.

Consent

Written informed consent has been obtained with permission for publishing of images.


Author's Contribution

P.K.S. and R.S. were the operating surgeons and prepared the manuscript. S.P. and P.M. worked on the pathological diagnosis. T.M. and B.R. finally read and critically revised the manuscript.


 
  • References

  • 1 Judson I, Demetri G. Advances in the treatment of gastrointestinal stromal tumours. Ann Oncol 2007; 18 (10) (Suppl. 10) x20-x24
  • 2 Miettinen M, Lasota J. Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001; 438 (01) 1-12
  • 3 Erlandson RA, Klimstra DS, Woodruff JM. Subclassification of gastrointestinal stromal tumors based on evaluation by electron microscopy and immunohistochemistry. Ultrastruct Pathol 1996; 20 (04) 373-393
  • 4 Iqbal N, Sharma A, Iqbal N. Clinicopathological and treatment analysis of 13 extragastrointestinal stromal tumors of mesentery and retroperitoneum. Ann Gastroenterol 2015; 28 (01) 105-108
  • 5 Pidhorecky I, Cheney RT, Kraybill WG, Gibbs JF. Gastrointestinal stromal tumors: current diagnosis, biologic behavior, and management. Ann Surg Oncol 2000; 7 (09) 705-712
  • 6 Li W, Cui Y, Ren G, Wang J, Wu X. Extragastrointestinal stromal tumor of the mesoappendix: CT findings and a review of the literature. World J Surg Oncol 2012; 10: 211
  • 7 Hou Y, Wang Y, Xu R, Li D, Zhao X. An extragastrointestinal stromal tumor originating from the seminal vesicles: a case report and review of the literature. Oncol Lett 2013; 6 (04) 947-949
  • 8 Krokowski M, Jocham D, Choi H, Feller AC, Horny HP. Malignant extragastrointestinal stromal tumor of bladder. J Urol 2003; 169 (05) 1790-1791
  • 9 Weppler EH, Gaertner EM. Malignant extragastrointestinal stromal tumor presenting as a vaginal mass: report of an unusual case with literature review. Int J Gynecol Cancer 2005; 15 (06) 1169-1172
  • 10 Lam MM, Corless CL, Goldblum JR, Heinrich MC, Downs-Kelly E, Rubin BP. Extragastrointestinal stromal tumors presenting as vulvovaginal/rectovaginal septal masses: a diagnostic pitfall. Int J Gynecol Pathol 2006; 25 (03) 288-292
  • 11 Vij M, Agrawal V, Pandey R. Malignant extra-gastrointestinal stromal tumor of the pancreas. A case report and review of literature. JOP 2011; 12 (02) 200-204
  • 12 Yi JH, Sim J, Park BB. , et al. The primary extra-gastrointestinal stromal tumor of pleura: a case report and a literature review. Jpn J Clin Oncol 2013; 43 (12) 1269-1272
  • 13 Zhang ZH, Feng GW, Liu ZF. , et al. A young man with primary prostatic extra-gastrointestinal stromal tumor: a rare case report and review of the literature. Int J Clin Exp Pathol 2014; 7 (04) 1764-1770
  • 14 Weiss S, Goldblum J, Folpe A. GIST and EGIST. Enzinger and Weiss's Soft Tissue Tumours. 6th ed. Philadelphia, PA: Elsevier; 2014: 569-590
  • 15 Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol 2008; 39 (10) 1411-1419
  • 16 Miettinen M, Wang ZF, Sarlomo-Rikala M, Osuch C, Rutkowski P, Lasota J. Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age. Am J Surg Pathol 2011; 35 (11) 1712-1721
  • 17 Llenas-García J, Guerra-Vales JM, Moreno A. , et al. Primary extragastrointestinal stromal tumors in the omentum and mesentery: a clinicopathological and immunohistochemical study. Hepatogastroenterology 2008; 55 (84) 1002-1005
  • 18 Shankar S, vanSonnenberg E, Desai J, Dipiro PJ, Van Den Abbeele A, Demetri GD. Gastrointestinal stromal tumor: new nodule-within-a-mass pattern of recurrence after partial response to imatinib mesylate. Radiology 2005; 235 (03) 892-898
  • 19 DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000; 231 (01) 51-58
  • 20 Debiec-Rychter M, Sciot R, Le Cesne A. , et al; EORTC Soft Tissue and Bone Sarcoma Group; Italian Sarcoma Group; Australasian GastroIntestinal Trials Group. KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours. Eur J Cancer 2006; 42 (08) 1093-1103